The Department of Translational Hematology and Oncology Research (THOR) conducts cancer research to develop and make available novel diagnostic tools, targeted therapies and clinical trials for direct use in patient care.

Department News

 

Cancer Treatment Approach Developed by LRI Researchers Proven Feasible in Clinical Study
09/20/2021

Dr. Scott invented a new radiation planning technique called Temporally Feathered Radiation Therapy to reduce toxicity, which has now been shown to be safe and feasible in a small clinical study.

Read More

 

Study Confirms Effectiveness of New Personalized Approach for Radiation Therapy
08/04/2021

Dr. Scott and colleagues validated the genomic-adjusted radiation dose to be beneficial as a pan-cancer predictor of radiation therapy efficacy in new clinical study.

Read More

 

LRI Postdoc Selected for Esteemed Howard Hughes Medical Institute Fellowship
02/18/2021

Dr. Card, a postdoctoral fellow in the Scott lab, has been named a 2020 Hanna Gray Fellow, a fellowship that helps provide support for underrepresented and early-career biomedical researchers.

Read More

More News